Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Carcinogenesis|January 10, 2006
Lack of stimulatory activity of a phytoestrogen-containing soy extract on the growth of breast cancer tumors in miceDaniela Gallo, Cristiano Ferlini, Manuela Fabrizi, et al.Biochemical Pharmacology|December 14, 2004
Thiocolchicine dimers: a novel class of topoisomerase-I inhibitorsGiuseppina Raspaglio, Cristiano Ferlini, Simona Mozzetti, et al.Current Cancer Drug Targets|January 29, 2008
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?Cristiano Ferlini, Giuseppina Raspaglio, Lucia Cicchillitti, et al.Oncology Research|December 15, 2010
RON and cisplatin resistance in ovarian cancer cell linesSilvia Prislei, Marisa Mariani, Giuseppina Raspaglio, et al.Molecular Cancer Therapeutics|January 12, 2008
From plasma membrane to cytoskeleton: a novel function for semaphorin 6ASilvia Prislei, Simona Mozzetti, Flavia Filippetti, et al.BMC Cancer|February 12, 2013
MiR-200c and HuR in ovarian cancerSilvia Prislei, Enrica Martinelli, Marisa Mariani, et al.Gene|January 8, 2008
Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking regionGiuseppina Raspaglio, Flavia Filippetti, Silvia Prislei, et al.Biochemical Pharmacology|September 12, 2012
Gli family transcription factors are drivers of patupilone resistance in ovarian cancerSimona Mozzetti, Enrica Martinelli, Giuseppina Raspaglio, et al.Oncotarget|July 3, 2015
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancerSilvia Prislei, Enrica Martinelli, Gian Franco Zannoni, et al.Cancer Research|December 17, 2008
Molecular mechanisms of patupilone resistanceSimona Mozzetti, Raffaella Iantomasi, Ilaria De Maria, et al.Pageof 2